Bausch Health Companies Inc. (BHC)

CA — Healthcare Sector

Peers: TEVA ELAN VTRS CTRA BHVN CPRI DHR

Automate Your Wheel Strategy on BHC

With Tiblio's Option Bot, you can configure your own wheel strategy including BHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol BHC
Rev/Share 26.5085
Book/Share 0.3963
PB -3.1313
Debt/Equity -28.4529
CurrentRatio 1.3093
ROIC 0.0123

MktCap 2385147558.0
FreeCF/Share 3.0246
PFCF 2.1261
PE 24.4113
Debt/Assets 0.7973
DivYield 0
ROE -0.0891

Rating C+
Score 2
Recommendation Sell
P/E Score 2
DCF Score 5
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
No ratings available.

News

Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates

BHC
Published: February 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Bausch Health (BHC) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.15 per share a year ago.

image for news Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

BHC
Published: February 14, 2025 by: Accesswire
Sentiment: Neutral

LAVAL, QC / ACCESS Newswire / February 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24.

image for news Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

BHC
Published: February 12, 2025 by: GlobeNewsWire
Sentiment: Neutral

Technological Advancements in Microcurrent and Radiofrequency Devices Propel Market Growth Technological Advancements in Microcurrent and Radiofrequency Devices Propel Market Growth

image for news Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More

1
2 (current)

About Bausch Health Companies Inc. (BHC)

IPO Date 1994-03-29
Website https://www.bauschhealth.com
Industry Drug Manufacturers - Specialty & Generic
CEO Thomas J. Appio
Employees 20700

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.